Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim
Clin Mol Hepatol 2019;25(4):390-399. Published online May 31, 2019
Background/Aims A risk prediction model for the development of hepatocellular carcinoma (HCC) from indeterminate nodules detected on computed tomography (CT) (RadCT score) in patients with chronic hepatitis B (CHB)-related cirrhosis was proposed. We validated this model for indeterminate nodules on magnetic resonance imaging (MRI).
Methods Between 2013 and 2016, Liver Imaging Reporting and Data System (LI-RADS) 2/3 nodules on MRI were detected in 99 patients with CHB. The RadCT score was calculated.
Results The median age of the 72 male and 27 female subjects was 58 years. HCC history and liver cirrhosis were found in 47 (47.5%) and 44 (44.4%) patients, respectively. The median RadCT score was 112. The patients with HCC (n=41, 41.4%) showed significantly higher RadCT scores than those without (median, 119 vs. 107; P=0.013); the Chinese university-HCC and risk estimation for HCC in CHB (REACH-B) scores were similar (both P>0.05). Arterial enhancement, T2 hyperintensity, and diffusion restriction on MRI were not significantly different in the univariate analysis (all P>0.05); only the RadCT score significantly predicted HCC (hazard ratio [HR]=1.018; P=0.007). Multivariate analysis showed HCC history was the only independent HCC predictor (HR=2.374; P=0.012). When the subjects were stratified into three risk groups based on the RadCT score (<60, 60–105, and >105), the cumulative HCC incidence was not significantly different among them (all P>0.05, log-rank test).
Conclusions HCC history, but not RadCT score, predicted CHB-related HCC development from LI-RADS 2/3 nodules. New risk models optimized for MRI-defined indeterminate nodules are required.
Citations
Citations to this article as recorded by
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim Yonsei Medical Journal.2024; 65(7): 371. CrossRef
Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim European Journal of Internal Medicine.2023; 107: 66. CrossRef
Early Detection of Hepatocarcinogenicity in Rats Using MRI with Ferric–Tannic Nanoparticles Jannarong Intakhad, Arpamas Vachiraarunwong, Jantira Sanit, Aiyarin Kittilukkana, Sarawut Kongkarnka, Rawiwan Wongpoomchai, Chalermchai Pilapong Analytical Chemistry.2023; 95(27): 10241. CrossRef
Cysteine‐rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling Hong‐Yu He, Li Hu The Kaohsiung Journal of Medical Sciences.2022; 38(1): 49. CrossRef
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim American Journal of Gastroenterology.2022; 117(2): 288. CrossRef
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef
Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma Wen-Qing Zou, Wei-Jie Luo, Yan-Fen Feng, Fang Liu, Shao-Bo Liang, Xue-Liang Fang, Ye-Lin Liang, Na Liu, Ya-Qin Wang, Yan-Ping Mao Frontiers in Immunology.2022;[Epub] CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2022; 14(3): 711. CrossRef
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim Journal of Viral Hepatitis.2021; 28(1): 95. CrossRef
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma Soojin Kim, Kyung Hyun Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim, Seung Up Kim Journal of Gastroenterology and Hepatology.2021; 36(5): 1317. CrossRef
Validation of the HCC‐RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy Fatih Güzelbulut, Pınar Gökçen, Güray Can, Gupse Adalı, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Kamil Özdil, Hamdi Levent Doğanay Journal of Viral Hepatitis.2021; 28(5): 826. CrossRef
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Current Oncology.2021; 28(1): 965. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma Myung Pyo Kim, Jae Kook Yang, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon, Hee Jae Jung, Jeong‐Ju Yoo, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee Journal of Viral Hepatitis.2021; 28(7): 1011. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim European Journal of Gastroenterology & Hepatology.2021; 33(12): 1564. CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1 Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2021; 13(23): 5892. CrossRef
Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Journal of Gastroenterology and Hepatology.2020; 35(10): 1795. CrossRef
Gadoxetic acid, a hepatocyte-specific magnetic resonance imaging (MRI) contrast agent, has emerged as an important tool for hepatocellular carcinoma (HCC) diagnosis. Gadoxetic acid-enhanced MRI is useful for the evaluation of earlystage HCC, diagnosis of HCC precursor lesions, and highly sensitive diagnosis of HCC. Furthermore, functional information provided by gadoxetic acid-enhanced MRI can aid in the characterization of focal liver lesions. For example, whereas lesions lack functioning hepatocytes appear hypointense in the hepatobiliary phase, preserved or enhanced expression of organic anion transporting polypeptides in some HCCs as well as focal nodular hyperplasia lead to hyperintensity in the hepatobiliary phase; and a targetoid appearance on transitional phase or hepatobiliary phase imaging can be helpful for identifying the histopathological composition of tumors. While gadoxetic acid-enhanced MRI may improve the sensitivity of HCC diagnosis and provide new insights into the characterization of focal liver lesions, there are many challenges associated with its use. This article reviews the pros and cons of HCC diagnosis with gadoxetic acid-enhanced MRI and discuss some clues in the radiological differentiation of HCC from HCC mimickers.
Citations
Citations to this article as recorded by
To Biopsy or Not to Biopsy? Re-examining the Role of Tissue Diagnosis in Hepatocellular Carcinoma Kaushal Madan, Ashish Kumar Journal of Clinical and Experimental Hepatology.2026; 16(1): 103209. CrossRef
Shrinking hemangiomas amid advancing cirrhosis: A report of 2 cases Hari Movva, Christo Mathew, Shiv Patel, Jimmy George, Vikas Burugu, Peeyush Bhargava Radiology Case Reports.2026; 21(4): 1429. CrossRef
Clinical significance of gadoxetate sodium-enhanced MRI for detecting liver metastasis in patients with pancreatic cancer: decadal real-world data analysis in Japan Atsushi Oba, Tomoyuki Taguchi, Naoto Fujikawa, Suguru Okami, Takashi Tsuji, Alexander Michel, Satoshi Goshima Journal of Gastroenterology.2026;[Epub] CrossRef
MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities Qiuye Wang, Yabing Sun, Liangxue Lai, Haijing Cui, Yonglong Ye, Ming Yang, Weihao Zhu, Bo Yuan, Quanliang Mao, Wenzhi Ren, Aiguo Wu Chinese Chemical Letters.2025; 36(4): 110212. CrossRef
Multiphase Computed Tomography Scan Findings for Artificial Intelligence Training in the Differentiation of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Interobserver Agreement of Expert Abdominal Radiologists Nakarin Inmutto, Suwalee Pojchamarnwiputh, Wittanee Na Chiangmai Diagnostics.2025; 15(7): 821. CrossRef
Diagnostic performances of adding transition and hepatobiliary phase to washout in gadoxetic acid-enhanced MRI for subcentimeter hepatocellular carcinoma Li Yang, Shengxiang Rao, Kaipu Jin, Lifang Wu, Mengsu Zeng, Ying Ding BMC Gastroenterology.2025;[Epub] CrossRef
Recent Advances in Magnetic Resonance Imaging for the Diagnosis of Liver Cancer: A Comprehensive Review Faisal Alshomrani Diagnostics.2025; 15(16): 2016. CrossRef
Predicting hepatic perfusion and clearance in hepatocellular carcinoma patients using Gd-EOB-DTPA-enhanced MRI Jinghui Feng, Xukun Zhang, Jinpeng Tan, Minghao Han, Dongxue Qi, Xiaoying Wang, Lihua Zhang Asian Journal of Surgery.2025;[Epub] CrossRef
Intra-patient and inter-observer image quality analysis in liver MRI study with gadoxetic acid using two different multi-arterial phase techniques Francesca Castagnoli, Riccardo Faletti, Riccardo Inchingolo, Alberta Villanacci, Valeria Ruggeri, Domenico Zacà, Dow-Mu Koh, Luigi Grazioli British Journal of Radiology.2024; 97(1156): 868. CrossRef
Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection Kyowon Gu, Ji Hye Min, Jeong Hyun Lee, Jaeseung Shin, Woo Kyoung Jeong, Young Kon Kim, Honsoul Kim, Sun-Young Baek, Jong Man Kim, Gyu Seong Choi, Jinsoo Rhu, Sang Yun Ha European Radiology.2024; 34(11): 7002. CrossRef
Review of imaging findings in hepatic veno-occlusive disease Samuel Simpson, Elliot Breshears, Deepashri Basavalingu, Garvit Khatri, Sherwin Chan, John Fite, Paul Swanson, Manjiri Dighe European Journal of Radiology.2024; 177: 111526. CrossRef
Clinical applications, safety profiles, and future developments of contrast agents in modern radiology: A comprehensive review Reabal Najjar iRADIOLOGY.2024; 2(5): 430. CrossRef
Suspected focal nodular hyperplasia in male adults: 10-year experience from a large liver centre Carmelo Corallo, Joshua Bell, Adam Laverty, Maryam Mohsin, Raj Prasad, Raneem Albazaz Abdominal Radiology.2023; 48(7): 2292. CrossRef
Gadoxetic acid in hepatocellular carcinoma and liver metastases: pearls and pitfalls H.M. Kwok, C.M. Chau, H.C.H. Lee, T. Wong, H.F. Chan, W.H. Luk, W.T.A. Yung, L.F. Cheng, K.F.J. Ma Clinical Radiology.2023; 78(10): 715. CrossRef
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management Bachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn Fowler, Tae Wook Kang, Gesine Knobloch, Dow-Mu Koh, Masatoshi Kudo, Jeong Min Lee, Takamichi Murakami, David J. Pinato, Kristina I. Ringe, Bin Song, Parissa Tabrizian, Jin Wang, European Radiology.2023; 33(12): 9152. CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2022; 14(3): 711. CrossRef
Dual-domain unsupervised network for removing motion artifact related to Gadoxetic acid-enhanced MRI Chongxin Bai, Kewen Liu, Shi Chen, Zhao Li, Weida Xie, Qingjia Bao, Chaoyang Liu Journal of Physics: Conference Series.2022; 2258(1): 012037. CrossRef
Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting Cher Heng Tan, Shu-cheng Chou, Nakarin Inmutto, Ke Ma, RuoFan Sheng, YingHong Shi, Zhongguo Zhou, Akira Yamada, Ryosuke Tateishi Korean Journal of Radiology.2022; 23(7): 697. CrossRef
Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study Yeo Eun Han, Yongwon Cho, Min Ju Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Ki Choon Sim, Yang Shin Park, Bit Na Park Abdominal Radiology.2022; 48(1): 244. CrossRef
Hepatobiliary phase of gadoxetic acid–enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE Jae Seok Bae, Jung Hoon Kim, Dong Ho Lee, Jae Hyun Kim, Joon Koo Han European Radiology.2021; 31(6): 3627. CrossRef
A Case of Metastatic Melanoma in the Liver Mimicking Hepatocellular Carcinoma Jae-Kyoung So, Ji-Yun Hong, Min-Woo Chung, Sung-Bum Cho Journal of Liver Cancer.2021; 21(1): 92. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef
Malignant Tumors Misdiagnosed as Liver Hemangiomas Murat Baki Yıldırım, İbrahim Tayfun Şahiner, Arzu Poyanlı, Bülent Acunaş, Mine Güllüoǧlu, Cem İbiş, Yaman Tekant, İlgin Özden Frontiers in Surgery.2021;[Epub] CrossRef
Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging Róbert Stollmayer, Bettina K Budai, Ambrus Tóth, Ildikó Kalina, Erika Hartmann, Péter Szoldán, Viktor Bérczi, Pál Maurovich-Horvat, Pál N Kaposi World Journal of Gastroenterology.2021; 27(35): 5978. CrossRef
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Hepatology International.2021; 15(5): 1083. CrossRef
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2021; 13(23): 5892. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma Han Ah Lee, Hyun Gil Goh, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Min-Goo Lee, Hyunggin An, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo BMC Gastroenterology.2021;[Epub] CrossRef
Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Gaabsoo Kim, Jae-Won Joh Annals of Surgical Treatment and Research.2021; 101(5): 257. CrossRef
Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram Seminars in Ultrasound, CT and MRI.2021; 42(4): 390. CrossRef
Management of indeterminate hepatic nodules and evaluation of factors predicting their malignant potential in patients with colorectal cancer Mizelle D’Silva, Jai Young Cho, Ho-Seong Han, Taupyk Yerlan, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim Scientific Reports.2021;[Epub] CrossRef
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma Han Ah Lee, Yoo Ra Lee, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo World Journal of Gastroenterology.2021; 27(28): 4687. CrossRef
Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis Abdominal Radiology.2021; 46(8): 3565. CrossRef
Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations Jae Hyon Park, Yong Eun Chung, Nieun Seo, Jin-Young Choi, Mi-Suk Park, Myeong-Jin Kim, Isabelle Chemin PLOS ONE.2021; 16(9): e0257308. CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1 Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2020; 12(9): 2527. CrossRef
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim Journal of Hepatocellular Carcinoma.2020; Volume 7: 403. CrossRef
Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study Chansik An, Chang Hee Lee, Jae Ho Byun, Min Hee Lee, Woo Kyoung Jeong, Sang Hyun Choi, Do Young Kim, Young-Suk Lim, Young Seok Kim, Ji Hoon Kim, Moon Seok Choi, Myeong-Jin Kim Korean Journal of Radiology.2019; 20(12): 1616. CrossRef
First
Prev
